企業プロフィール

Genprex 株価・ニュース・カタリスト

ティッカー:: GNPX
取引所:: NASDAQ
セクター:: Biopharma
所在地:: United States

株価パフォーマンス

4.47 USD (+3.59%)

終値

最終更新: 2026年8月17日

7.78M USD

時価総額

株価変動の要因

As of Aug 17, 2026, GNPX closed up 3.59% at $4.47. No new same-company headline was identified in the current news window.

企業概要

事業概要

Genprex is a gene-therapy and oncology company focused on cancer and diabetes-related programs. Its platform has long centered on genetic medicine in difficult disease settings.

所在地とセクター分類

Headquartered in the United States and listed on NASDAQ, Genprex sits in specialty biotechnology.

ビジネスモデルの特徴

The company depends on platform validation, clinical progress, and the ability to translate gene-delivery science into value.

バイオ業界での位置付け

Genprex is a high-catalyst genetic-medicine name with strong dependence on early results.

今後のカタリスト

Genprex’s catalysts are the oncology and diabetes platforms, plus any strategic update that shows the company can still create value. The market needs a more convincing clinical path.